132 related articles for article (PubMed ID: 31491747)
1. Bone mineral density, body composition and metabolic profiles in adult women with complete androgen insensitivity syndrome and removed gonads using oral or transdermal estrogens.
Gava G; Mancini I; Orsili I; Bertelloni S; Alvisi S; Seracchioli R; Meriggiola MC
Eur J Endocrinol; 2019 Dec; 181(6):711-718. PubMed ID: 31491747
[TBL] [Abstract][Full Text] [Related]
2. Bone Mineral Density in Women Living with Complete Androgen Insensitivity Syndrome and Intact Testes or Removed Gonads.
Bertelloni S; Meriggiola MC; Dati E; Balsamo A; Baroncelli GI
Sex Dev; 2017; 11(4):182-189. PubMed ID: 28715798
[TBL] [Abstract][Full Text] [Related]
3. Case Report: Low Bone and Normal Lean Mass in Adolescents With Complete Androgen Insensitivity Syndrome.
Misakian A; McLoughlin M; Pyle LC; Kolon TF; Kelly A; Vogiatzi MG
Front Endocrinol (Lausanne); 2021; 12():727131. PubMed ID: 34526969
[TBL] [Abstract][Full Text] [Related]
4. Altered bone mineral density in patients with complete androgen insensitivity syndrome.
Bertelloni S; Baroncelli GI; Federico G; Cappa M; Lala R; Saggese G
Horm Res; 1998; 50(6):309-14. PubMed ID: 9973670
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density in complete androgen insensitivity syndrome and the timing of gonadectomy.
King TFJ; Wat WZM; Creighton SM; Conway GS
Clin Endocrinol (Oxf); 2017 Aug; 87(2):136-140. PubMed ID: 28493277
[TBL] [Abstract][Full Text] [Related]
6. Comparison of bone mineral density and body proportions between women with complete androgen insensitivity syndrome and women with gonadal dysgenesis.
Han TS; Goswami D; Trikudanathan S; Creighton SM; Conway GS
Eur J Endocrinol; 2008 Aug; 159(2):179-85. PubMed ID: 18463105
[TBL] [Abstract][Full Text] [Related]
7. [Study of bone mineral density in complete androgen insensitivity syndrome patients].
Tian QJ; Dai ZQ; Yu W; Tian JP; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):799-802. PubMed ID: 16412322
[TBL] [Abstract][Full Text] [Related]
8. Changes in bone mineral density after orchidectomy and hormone replacement therapy in individuals with androgen insensitivity syndrome.
Mizunuma H; Soda M; Okano H; Kagami I; Miyamoto S; Ohsawa M; Ibuki Y
Hum Reprod; 1998 Oct; 13(1O):2816-8. PubMed ID: 9804237
[TBL] [Abstract][Full Text] [Related]
9. The contribution of testosterone to skeletal development and maintenance: lessons from the androgen insensitivity syndrome.
Marcus R; Leary D; Schneider DL; Shane E; Favus M; Quigley CA
J Clin Endocrinol Metab; 2000 Mar; 85(3):1032-7. PubMed ID: 10720035
[TBL] [Abstract][Full Text] [Related]
10. Hormonal management of complete androgen insensitivity syndrome from adolescence onward.
Bertelloni S; Dati E; Baroncelli GI; Hiort O
Horm Res Paediatr; 2011; 76(6):428-33. PubMed ID: 22156544
[TBL] [Abstract][Full Text] [Related]
11. Body composition and metabolic profile in women with complete androgen insensitivity syndrome.
Dati E; Baroncelli GI; Mora S; Russo G; Baldinotti F; Parrini D; Erba P; Simi P; Bertelloni S
Sex Dev; 2009; 3(4):188-93. PubMed ID: 19752598
[TBL] [Abstract][Full Text] [Related]
12. Height and bone mineral density in androgen insensitivity syndrome with mutations in the androgen receptor gene.
Danilovic DL; Correa PH; Costa EM; Melo KF; Mendonca BB; Arnhold IJ
Osteoporos Int; 2007 Mar; 18(3):369-74. PubMed ID: 17077943
[TBL] [Abstract][Full Text] [Related]
13. Oestrogen versus androgen in hormone-replacement therapy for complete androgen insensitivity syndrome: a multicentre, randomised, double-dummy, double-blind crossover trial.
Birnbaum W; Marshall L; Werner R; Kulle A; Holterhus PM; Rall K; Köhler B; Richter-Unruh A; Hartmann MF; Wudy SA; Auer MK; Lux A; Kropf S; Hiort O
Lancet Diabetes Endocrinol; 2018 Oct; 6(10):771-780. PubMed ID: 30075954
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of body composition and bone mineral density in women with rheumatoid arthritis].
Silva RG; Pippa MG; Zerbin CA
Rev Assoc Med Bras (1992); 2007; 53(2):135-41. PubMed ID: 17568917
[TBL] [Abstract][Full Text] [Related]
15. Retinol-binding protein 4 is positively associated with bone mineral density in patients with type 2 diabetes and osteopenia or osteoporosis.
Huang N; Zhou J; Wang W; Wang Q; Tang Y; Sun Y; Wang D; Chen S
Clin Endocrinol (Oxf); 2018 May; 88(5):659-664. PubMed ID: 29394455
[TBL] [Abstract][Full Text] [Related]
16. Frequency of gonadal tumours in complete androgen insensitivity syndrome (CAIS): A retrospective case-series analysis.
Chaudhry S; Tadokoro-Cuccaro R; Hannema SE; Acerini CL; Hughes IA
J Pediatr Urol; 2017 Oct; 13(5):498.e1-498.e6. PubMed ID: 28351649
[TBL] [Abstract][Full Text] [Related]
17. Decreased bone mineral density in Costello syndrome.
Leoni C; Stevenson DA; Martini L; De Sanctis R; Mascolo G; Pantaleoni F; De Santis S; La Torraca I; Persichilli S; Caradonna P; Tartaglia M; Zampino G
Mol Genet Metab; 2014 Jan; 111(1):41-5. PubMed ID: 24246682
[TBL] [Abstract][Full Text] [Related]
18. Body composition, bone mineral density and fractures in late postmenopausal women with polycystic ovary syndrome - a long-term follow-up study.
Schmidt J; Dahlgren E; Brännström M; Landin-Wilhelmsen K
Clin Endocrinol (Oxf); 2012 Aug; 77(2):207-14. PubMed ID: 22385110
[TBL] [Abstract][Full Text] [Related]
19. Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort.
Segaud N; Legroux I; Hazzan M; Noel C; Cortet B
Osteoporos Int; 2018 May; 29(5):1165-1175. PubMed ID: 29500526
[TBL] [Abstract][Full Text] [Related]
20. Characteristic features of reproductive hormone profiles in late adolescent and adult females with complete androgen insensitivity syndrome.
Doehnert U; Bertelloni S; Werner R; Dati E; Hiort O
Sex Dev; 2015; 9(2):69-74. PubMed ID: 25613104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
